Manager, Merchant Lending, SMB Sales
Location
Arizona + 4 moreAll locations: Arizona, Illinois, Nebraska, New York, Texas
Posted
4 days ago
Salary
$135K - $213.4K / year
Job Description
Job Requirements
- 5+ years relevant experience
- Bachelor’s degree or equivalent combination of education and experience
- 3+ years in a revenue-generating role with quota accountability
- 2+ years of direct people leadership experience
- Strong performance management skills
- Financial Services / Fintech and Lending experience is a strong plus
Benefits
- Generous paid time off
- Healthcare coverage for you and your family
- Support for mental health
- Flexible work arrangements
Related Guides
Related Job Pages
More Sales Jobs
Senior/Advanced Lung Disease Specialist (Kansas City, MO) *Rare Disease Opportunity*
United Therapeutics CorporationWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Advanced Lung Disease (ALD) Specialist is responsible for maintaining and increasing sales of all UT products, primarily Tyvaso, within a defined territory by executing sales and marketing strategies and serving as an educational resource for healthcare professionals treating PH-ILD and/or IPF.
Senior/Advanced Lung Disease Specialist (Salt Lake City, UT) *Rare Disease Opportunity*
United Therapeutics CorporationWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Advanced Lung Disease Specialist is responsible for maintaining and increasing sales of all UT products, primarily Tyvaso, within a defined territory by executing sales and marketing strategies and serving as an educational resource for healthcare professionals treating PH-ILD and/or IPF.
Senior/Advanced Lung Disease Specialist (Seattle, WA) *Rare Disease Opportunity*
United Therapeutics CorporationWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Advanced Lung Disease (ALD) Specialist is responsible for maintaining and increasing sales of all UT products, primarily Tyvaso, within a defined territory by executing sales and marketing strategies and serving as an educational resource for healthcare professionals treating PH-ILD and/or IPF patients. This involves building professional relationships with various customer types, analyzing sales data to develop business plans, and ensuring maximal product messaging and education.
The Territory Manager III will lead sales strategy within an assigned territory to achieve sales volume, market penetration, and profitability objectives, ensuring alignment with team and leadership goals. This role involves identifying and capitalizing on sales opportunities by building competency and expertise in Company therapies among physicians and customers in a highly matrixed environment.
